| Not yet recruiting | 2 | 30 | | | Western Sydney Local Health District, Sydney West Radiation Oncology Network | Metastatic Cancer (brain metastases) | | | | |
| Recruiting | 2 | 30 | | | Western Sydney Local Health District, Sydney West Radiation Oncology Network | Metastatic Cancer (brain metastases) | | | | |
OUTRUN, NCT03497767: A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases |
|
|
| Completed | 2 | 40 | RoW | Osimertinib, Tagrisso, Stereotactic Radiosurgery (SRS) | Trans Tasman Radiation Oncology Group | Metastatic Non Small Cell Lung Cancer | 04/24 | 04/24 | | |